These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system. Ikegami M; Ikeda H; Ohashi T; Kai M; Osada M; Kamei A; Kamei J Neuroendocrinology; 2013; 98(3):224-32. PubMed ID: 24135197 [TBL] [Abstract][Full Text] [Related]
32. Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice. Kapse S; Ando H; Fujiwara Y; Suzuki C; Ushijima K; Kitamura H; Hosohata K; Kotani K; Shimba S; Fujimura A J Pharmacol Sci; 2017 Mar; 133(3):139-145. PubMed ID: 28279595 [TBL] [Abstract][Full Text] [Related]
33. The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice. Grajales D; Vázquez P; Ruíz-Rosario M; Tudurí E; Mirasierra M; Ferreira V; Hitos AB; Koller D; Zubiaur P; Cigudosa JC; Abad-Santos F; Vallejo M; Quesada I; Tirosh B; Leibowitz G; Valverde ÁM Diabetologia; 2022 Mar; 65(3):490-505. PubMed ID: 34932133 [TBL] [Abstract][Full Text] [Related]
34. One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects. Ersland KM; Myrmel LS; Fjære E; Berge RK; Madsen L; Steen VM; Skrede S Int J Neuropsychopharmacol; 2019 May; 22(5):358-369. PubMed ID: 30854556 [TBL] [Abstract][Full Text] [Related]
35. Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats. Boyda HN; Procyshyn RM; Tse L; Wong D; Pang CC; Honer WG; Barr AM Neuropharmacology; 2012 Mar; 62(3):1391-400. PubMed ID: 21376062 [TBL] [Abstract][Full Text] [Related]
36. Severe hyperglycemia induced by olanzapine was improved with a recovery of insulin secretion after switching to risperidone and introducing insulin therapy. Nakamura M; Nagamine T Intern Med; 2010; 49(23):2635-7. PubMed ID: 21139307 [TBL] [Abstract][Full Text] [Related]
37. Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells. Engl J; Laimer M; Niederwanger A; Kranebitter M; Starzinger M; Pedrini MT; Fleischhacker WW; Patsch JR; Ebenbichler CF Mol Psychiatry; 2005 Dec; 10(12):1089-96. PubMed ID: 16130009 [TBL] [Abstract][Full Text] [Related]
38. Olanzapine induces glucose intolerance through the activation of AMPK in the mouse hypothalamus. Ikegami M; Ikeda H; Ishikawa Y; Ohsawa M; Ohashi T; Kai M; Kamei A; Kamei J Eur J Pharmacol; 2013 Oct; 718(1-3):376-82. PubMed ID: 23973646 [TBL] [Abstract][Full Text] [Related]
39. Insulin resistance induced by olanzapine and other second-generation antipsychotics in Chinese patients with schizophrenia: a comparative review and meta-analysis. Yu L; Wu S; Deng Y; Lei J; Yu L; Li W Eur J Clin Pharmacol; 2019 Dec; 75(12):1621-1629. PubMed ID: 31428814 [TBL] [Abstract][Full Text] [Related]
40. Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats. Boyda HN; Ramos-Miguel A; Procyshyn RM; Töpfer E; Lant N; Choy HH; Wong R; Li L; Pang CC; Honer WG; Barr AM Int J Neuropsychopharmacol; 2014 Jan; 17(1):77-90. PubMed ID: 23953063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]